Inhibitors of the TGF-β Superfamily and their Clinical Applications

Author(s): K. Tsuchida, Y. Sunada, S. Noji, T. Murakami, A. Uezumi, M. Nakatani.

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 6 , Issue 11 , 2006

Become EABM
Become Reviewer

Abstract:

The transforming growth factor-β (TGF-β) superfamily includes TGF-β s, activin, myostatin and bone morphogenetic proteins. Misregulation of the activity of TGF-β family members is involved in pathogenesis of cancer, muscular dystrophy, obesity and bone and tooth remodeling. Natural inhibitors for the TGF-β superfamily regulate fine-tuning of activity of TGF-β family in vivo. In addition to natural inhibitors for the TGF-βfamily, soluble forms of receptors for the TGF-β family, blocking monoclonal antibodies and small chemical TGF-β inhibitors have been developed. In this review, we summarize recent advances in our understanding of inhibitors for the TGF-β superfamily and their medical applications.

Keywords: TGF-β, activin, BMP, cancer, fibrosis, follistatin, myostatin, muscular dystrophy

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 6
ISSUE: 11
Year: 2006
Page: [1255 - 1261]
Pages: 7
DOI: 10.2174/138955706778742759
Price: $58

Article Metrics

PDF: 15